Genomic Profiling of Pediatric Solid Tumors With a Dual DNA/RNA Panel: JCCG‐TOP2 Study
In the JCCG‐TOP2 nationwide pediatric cancer genomic profiling study, 204 patients' tumors and peripheral blood from 50 institutions across Japan were successfully analyzed using a dual DNA/RNA panel. A total of 147 (72%) had potentially actionable findings, including diagnostic, prognostic, and therapeutic findings in 111 (54%), 61 (30%), and 64 (31%),
Kayoko Tao +38 more
wiley +1 more source
Bee products as alternatives in the treatment of viral infections
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba +3 more
wiley +1 more source
We report on a 16-year-old male with paratesticular rhabdomyosarcoma who underwent retroperitoneal lymph node dissection due to a stage I tumor (normal retroperitoneal computed tomoghaphy).
Eulalio Damazio +3 more
doaj +1 more source
Correction to: Testosterone-mediated activation of androgenic signaling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines [PDF]
Léo Dutra Cabistany +3 more
openalex +1 more source
Embryonic rhabdomyosarcoma presenting as Gradenigo’s syndrome: Figure 1 [PDF]
Rupert George Ricks, L. C. Hollis
openalex +1 more source
Long-term urological complications after conservative local treatment (surgery and brachytherapy) in children with bladder-prostate rhabdomyosarcoma. A single team experience. [PDF]
Rezkalla Akkary +8 more
openalex +1 more source
Rhabdomyosarcoma (sarcoma botryoides) of the common bile duct.Report of a case [PDF]
Robert C. Horn +3 more
openalex +1 more source
Alveolar Rhabdomyosarcoma in a Child with Diffuse Bone Marrow Involvement and Chromosomal Translocation (2;13) [PDF]
Nur Olgun +7 more
openalex +1 more source

